The study focused on 25 pathways, such as the relaxin signaling pathway, fluid shear stress and atherosclerosis, and the AGE-RAGE signaling pathway, a complication of diabetes, which have been implicated in the treatment of RAU. This evidence concerns the gene RENBP and atherosclerosis.